IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

IBE

19.195

-1.72%↓

ORA

18.23

-1.43%↓

ELE

36.13

-1.23%↓

FORTUM.FI

20.19

0%↓

ELEC.FR

237

-2.07%↓

Home・Aandelen Lijst・STRATEC Biomedical AG

STRATEC Biomedical AG

Gesloten

16.72 -5.54

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

16.5

Max

17.28

Belangrijke statistieken
By Trading Economics
Inkomsten	-5.8M -4.3M
Verkoop	18M 75M
K/W Sectorgemiddelde	14.63 26.79
EPS	-0.357
Winstmarge	-5.772
Werknemers	1,343
EBITDA	2.9M 11M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+63.1% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-12M 214M
Vorige openingsprijs	22.26
Vorige sluitingsprijs	16.72

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

N/A / 24.5 Steun & Weerstand

STRATEC Biomedical AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 jul 2025, 17:24 UTC

Marktinformatie

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Peer Vergelijking

Prijswijziging

STRATEC Biomedical AG Prognose

Koersdoel

By TipRanks

63.1% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 29 EUR 63.1%

Hoogste 37 EUR

Laagste 21 EUR

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor STRATEC Biomedical AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan STRATEC Biomedical AG - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

N/A / 24.5Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.